×

Health Care Equipment and Supplies John Hammergren

  • The company's shares were up 6.2 percent at $150.30 in after-market trading on Thursday. The company said it expects fiscal 2018 adjusted earnings of $11.75- $12.45 per share. However, Walgreens Boot Alliance deal for Rite Aid in 2015 cast doubts over that contract.

  • "Although we were unfavorably impacted in the third quarter by weaker branded pharmaceutical pricing than anticipated, we are updating our fiscal 2017 outlook to reflect McKesson's lower full-year effective tax rate," CEO John Hammergren said in a statement on Wednesday. "We would have preferred that McKesson focus its M&A strategy more on healthcare...

  • Net income attributable to McKesson was $633 million, or $2.85 per share, in the third quarter ended Dec. 31, from $634 million, or $2.73 per share, a year earlier. Revenue rose to $50.13 billion from about $47.90 billion, compared with estimates of about $50.50 billion. McKesson said on Wednesday it expects adjusted earnings from continuing operations of $12.60-...

  • Jan 17- McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers. Tuesday's deal with the U.S. Justice Department followed an earlier settlement with the company over similar violations in 2008.